Erratum for

• Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study.

  Shi Z, Fu LP, Zhang N, Zhao X, Liu S, Zuo C, Cai L, Wang Y, Gao S, Ai L, Guan YH, Xu B, Ji Y. Shi Z, et al. J Nucl Med. 2020 Dec;61(12):1814-1819. doi: 10.2967/jnumed.119.240325. Epub 2020 May 8. J Nucl Med. 2020. PMID: 32385166
• ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience.

  Sartor O, Fougère C, Essler M, Ezziddin S, Kramer G, Ellinger J, Nordquist L, Sylvester J, Paganelli G, Peer A, Bögemann M, Meltzer J, Sandström P, Verholen F, Song DY. Sartor O, et al. J Nucl Med. 2022 Mar;63(3):410-414. doi: 10.2967/jnumed.121.262240. Epub 2021 Jun 24. J Nucl Med. 2022. PMID: 34168015 Free PMC article.
• Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.

  Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y. Radchenko V, et al. J Nucl Med. 2021 Nov;62(11):1495-1503. doi: 10.2967/jnumed.120.261016. Epub 2021 Jul 22. J Nucl Med. 2021. PMID: 34301779 Free PMC article. Review.
• ¹⁸F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies.

  Minoshima S, Cross D, Thientunyakit T, Foster NL, Drzezga A. Minoshima S, et al. J Nucl Med. 2022 Jun;63(Suppl 1):2S-12S. doi: 10.2967/jnumed.121.263194. J Nucl Med. 2022. PMID: 35649653